2025-08-29 03:10:14
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
JB Chemicals and Pharmaceuticals Ltd Q4 FY2022 consolidated PAT up QoQ at Rs. 84.84 crores
Posted On : 2022-05-26 21:50:52( TIMEZONE : IST )
JB Chemicals & Pharmaceuticals Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 626.6678 crores during the period ended March 31, 2022 as compared to Rs. 605.1838 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 84.8450 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 83.8860 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 10.96 for the period ended March 31, 2022 as compared to Rs. 10.82 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 626.6678 crs | ₹605.1838 crs |  3.55% |
| Net Profit | ₹84.8450 crs | ₹83.8860 crs | 1.14% |
| EPS | ₹10.96 | ₹10.82 | 1.29% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 626.6678 crores during the period ended March 31, 2022 as compared to Rs.553.8037 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.84.8450 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.100.6125 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.10.96 for the period ended March 31, 2022 as compared to Rs.13.02 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 626.6678 crs | ₹553.8037 crs | 13.16% |
| Net Profit | ₹84.8450 crs | ₹100.6125 crs |  -15.67% |
| EPS | ₹10.96 | ₹13.02 | -15.82% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.2463.4701 crores during the Financial Year ended March 31, 2022 as compared to Rs.2154.9047 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.385.3574 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.447.9636 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.49.82 for the Financial Year ended March 31, 2022 as compared to Rs.57.96 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹2463.4701 crs | ₹2154.9047 crs | 14.32% |
| Net Profit | ₹385.3574 crs | ₹447.9636 crs | -13.98% |
| EPS | ₹49.82 | ₹57.96 | -14.04% |
Shares of JB Chemicals & Pharmaceuticals Limited was last trading in BSE at Rs. 1562.75 as compared to the previous close of Rs. 1568.90. The total number of shares traded during the day was 2161 in over 697 trades.
The stock hit an intraday high of Rs. 1579.75 and intraday low of 1548.35. The net turnover during the day was Rs. 3379007.00.
